the orexin hypocretin system physiology and pathophysiology
The Orexin/Hypocretin System: Physiology and Pathophysiology
$291.00 Original price was: $291.00.$4.99Current price is: $4.99. Add to cart
Sale!

The Orexin/Hypocretin System: Physiology and Pathophysiology

Original price was: $291.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Master Switch of Arousal: The Orexin/Hypocretin System

In 1998, the discovery of two novel neuropeptides—orexin A and B (also known as hypocretins)—revolutionized our understanding of the brain. Produced by a tiny cluster of neurons in the lateral hypothalamus, this system is the master orchestrator of sleep, wakefulness, appetite, and reward. When these neurons die, the result is the devastating sleep disorder, narcolepsy. The Orexin/Hypocretin System: Physiology and Pathophysiology is the definitive, fiercely advanced neurobiological text detailing this critical neural network. This volume provides the exact blueprints required by neuroscientists and sleep medicine physicians to understand the profound systemic impact of orexinergic signaling.

Mastering Narcolepsy and Sleep-Wake Regulation

The core philosophy of this text is translational neurobiology. The authors aggressively detail the pathophysiology of Type 1 Narcolepsy, dictating exactly how the autoimmune destruction of orexin-producing neurons leads directly to the collapse of the sleep-wake boundary, resulting in overwhelming daytime sleepiness and cataplexy (sudden loss of muscle tone triggered by emotion).

Navigating Addiction, Metabolism, and Novel Therapeutics

The book provides a masterclass in the broader systemic role of orexins. It dictates the exact neural pathways linking the orexin system to the ventral tegmental area (VTA), explaining its crucial role in reward-seeking behavior and drug addiction. It provides exhaustive reviews of the development of Dual Orexin Receptor Antagonists (DORAs), the revolutionary new class of insomnia medications (like suvorexant) that work by turning off the brain’s “wake” switch rather than forcing sedation.

Frequently Asked Questions (FAQs)

Does this book cover the genetic basis of narcolepsy?
Yes, it features critical chapters detailing the strong association between narcolepsy and the HLA-DQB1*06:02 allele, providing the genetic framework for the autoimmune hypothesis of the disease.

Who is the primary audience?
It is the absolute, mandatory reference for Sleep Medicine Physicians, Neuroscientists, Neuropharmacologists, and Researchers studying addiction and metabolism.